Evaluation on the clinical utilization of human serum albumin in ICU patients

VernacularTitle:人血白蛋白在危重症患者中临床应用的评价
Author: Ting ZHOU ¹ ; Zhen YANG ; Saihua LU ; Xiufeng LIU ; Ye ZHANG ; Feng XU
Author Information

1. 上海交通大学附属第六人民医院南院药剂科
Keywords: human serum albumin(HSA); rational use; evaluate; intensive care patients
From: Journal of Pharmaceutical Practice 2017;35(2):167-170
CountryChina
Language:Chinese
Abstract: Objective To evaluate the utilization of human serum albumin (HSA ) in intensive care unit (ICU ) to pro-mote rational use of HSA clinically .Methods Data were collected from the patients received HSA therapy during the period of January 1 ,2015 to December 31 ,2015 .The indications and usage of HSA were analyzed statistically .Results 416 bottles of HSA were administered to 64 patients .The average dose was 62 .5g per patient .The most popular indication was for hypopro-teinemia (39 .1% ) followed by encephaledema ,craniocerebral trauma ,shock and tumors .Before the HSA therapy ,36 patients (56 .3% ) had albumin level of 15-25 g/L and 23 patients (35 .9% ) of 25-35 g/L .Conclusion HSA is widely used in ICU for different indications .Some misuses still exist .Guidelines for proper use of HSA are needed to guarantee its rational use .HSA should be used strictly following these guidelines .